Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Bartholini

Showing results (21-30 of 98) with videos related to

Pageof 10
Sort By:
Naunyn-Schmiedeberg'S Archives of Pharmacology|January 1, 1972
Demethylation of L-3-methoxytyrosine in vivoG Bartholini, A Pletscher
Revue Neurologique|July 1, 1972
[Monoamines and thymic regulation]R Tissot, G Bartholini
Actualites Pharmacologiques|January 1, 1971
[Dopa metabolism in relation to the therapy of Parkinson's syndrome]A Pletscher, G Bartholini
Experientia|May 15, 1975
The effect of drugs on the release of endogenous catecholamines into the perfusate of discrete brain areas of the cat in vivoK G Lloyd, G Bartholini
Journal of Neural Transmission. Supplementum|January 1, 1980
The potential of GABA-mimetics in the therapy of extrapyramidal disordersG Bartholini, K G Lloyd
Naunyn-Schmiedeberg'S Archives of Pharmacology|March 22, 1974
Proceedings: Thyrotropin-releasing hormone: activation of cerebral noradrenaline turnoverH H Keller, G Bartholini
Advances in Biochemical Psychopharmacology|January 1, 1974
The effect of methiothepin on cerebral monoamine neuronsK G Lloyd, G Bartholini
Pharmacology & Therapeutics. Part B: General & Systematic Pharmacology|January 1, 1976
Monoaminergic drugs: general pharmacologyW Haefely, G Bartholini, A Pletscher
European Journal of Pharmacology|October 1, 1984
Involvement of the D-2 dopamine receptor in the neuroleptic-induced decrease in nigral substance PA Oblin, B Zivkovic, G Bartholini
The Journal of Pharmacology and Experimental Therapeutics|October 1, 1972
The metabolic pathways of L-3-O-methyldopaG Bartholini, I Kuruma, A Pletscher
Pageof 10

Showing results (21-30 of 98) with videos related to

Sort By:
Pageof 10
Naunyn-Schmiedeberg'S Archives of Pharmacology|January 1, 1972
Demethylation of L-3-methoxytyrosine in vivoG Bartholini, A Pletscher
Revue Neurologique|July 1, 1972
[Monoamines and thymic regulation]R Tissot, G Bartholini
Actualites Pharmacologiques|January 1, 1971
[Dopa metabolism in relation to the therapy of Parkinson's syndrome]A Pletscher, G Bartholini
Experientia|May 15, 1975
The effect of drugs on the release of endogenous catecholamines into the perfusate of discrete brain areas of the cat in vivoK G Lloyd, G Bartholini
Journal of Neural Transmission. Supplementum|January 1, 1980
The potential of GABA-mimetics in the therapy of extrapyramidal disordersG Bartholini, K G Lloyd
Naunyn-Schmiedeberg'S Archives of Pharmacology|March 22, 1974
Proceedings: Thyrotropin-releasing hormone: activation of cerebral noradrenaline turnoverH H Keller, G Bartholini
Advances in Biochemical Psychopharmacology|January 1, 1974
The effect of methiothepin on cerebral monoamine neuronsK G Lloyd, G Bartholini
Pharmacology & Therapeutics. Part B: General & Systematic Pharmacology|January 1, 1976
Monoaminergic drugs: general pharmacologyW Haefely, G Bartholini, A Pletscher
European Journal of Pharmacology|October 1, 1984
Involvement of the D-2 dopamine receptor in the neuroleptic-induced decrease in nigral substance PA Oblin, B Zivkovic, G Bartholini
The Journal of Pharmacology and Experimental Therapeutics|October 1, 1972
The metabolic pathways of L-3-O-methyldopaG Bartholini, I Kuruma, A Pletscher
Pageof 10